Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides (TECLA)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by University of Cologne.
Recruitment status was  Not yet recruiting
Information provided by (Responsible Party):
Prof. Dr. med. Dr. rer. nat Cornelia Mauch, University of Cologne Identifier:
First received: July 11, 2012
Last updated: July 17, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given